These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4068572)

  • 1. [Fibronectins: a possible treatment of therapy-resistant corneal ulcers].
    Harnisch JP; Sinha PK
    Klin Monbl Augenheilkd; 1985 Jul; 187(1):53-6. PubMed ID: 4068572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical fibronectin treatment in persistent corneal epithelial defects and corneal ulcers.
    Kim KS; Oh JS; Kim IS; Jo JS
    Korean J Ophthalmol; 1990 Jun; 4(1):5-11. PubMed ID: 2214253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical fibronectin therapy in persistent corneal ulceration.
    McCluskey P; Wakefield D; York L
    Aust N Z J Ophthalmol; 1987 Nov; 15(4):257-62. PubMed ID: 3435668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fibronectin and corneal ulcer].
    Rigal D; Bastide P; Corny S
    Bull Soc Ophtalmol Fr; 1988 May; 88(5):711-2. PubMed ID: 3228956
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid preparation of purified autologous fibronectin eyedrops from patient's plasma.
    Nishida T; Nakagawa S; Awata T; Nishibayashi C; Manabe R
    Jpn J Ophthalmol; 1982; 26(4):416-24. PubMed ID: 7166901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical fibronectin in the treatment of persistent corneal epithelial defects and trophic ulcers.
    Phan TM; Foster CS; Boruchoff SA; Zagachin LM; Colvin RB
    Am J Ophthalmol; 1987 Nov; 104(5):494-501. PubMed ID: 3674183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical fibronectin therapy of persistent corneal epithelial defects. Fibronectin Study Group.
    McCulley JP; Horowitz B; Husseini ZM; Horowitz M
    Trans Am Ophthalmol Soc; 1993; 91():367-86; discussion 386-90. PubMed ID: 8140699
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibronectin. A new therapy for corneal trophic ulcer.
    Nishida T; Ohashi Y; Awata T; Manabe R
    Arch Ophthalmol; 1983 Jul; 101(7):1046-8. PubMed ID: 6870626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The efficiency of treating ulcerative corneal lesions with fibro nectin].
    Adamova NA; Gorgiladze TU; Artemov AV
    Oftalmol Zh; 1990; (4):245-8. PubMed ID: 2255507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cultural study on corneal explants and clinic assessment of the effectiveness of treating corneal ulcers induced by alkal test with topic aprotinin and fibronectin.
    Cosimi MF; Cerqueti MP; Lomolino G; Re P; Casagranda I
    Pathologica; 1994 Feb; 86(1):74-6. PubMed ID: 7521030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of fibronectin eyedrops on epithelial disorders after herpetic keratitis.
    Nishida T; Nakagawa S; Manabe R
    Ophthalmology; 1985 Feb; 92(2):213-6. PubMed ID: 3982800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of persistent corneal epithelial disorders with human plasma fibronectin eyedrops].
    Qu XA
    Zhonghua Yan Ke Za Zhi; 1990 Jan; 26(1):21-3. PubMed ID: 2373030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of autologous platelet-rich plasma in the treatment of dormant corneal ulcers.
    Alio JL; Abad M; Artola A; Rodriguez-Prats JL; Pastor S; Ruiz-Colecha J
    Ophthalmology; 2007 Jul; 114(7):1286-1293.e1. PubMed ID: 17324465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of human plasma fibronectin using immobilized gelatin and Arg affinity chromatography.
    Speziale P; Visai L; Rindi S; Di Poto A
    Nat Protoc; 2008; 3(3):525-33. PubMed ID: 18323821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on preparation of a wound healing agent: fibronectin].
    Ren G; Huang X; Dai L; Ye H; Liang P
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Sep; 20(3):531-3. PubMed ID: 14565032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma fibronectin: three steps to purification and stability.
    Poulouin L; Gallet O; Rouahi M; Imhoff JM
    Protein Expr Purif; 1999 Oct; 17(1):146-52. PubMed ID: 10497080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of topical fixed-combination fortified vancomycin-amikacin (VA solution) to conventional separate therapy in the treatment of bacterial corneal ulcer.
    Chiang CC; Lin JM; Chen WL; Chiu YT; Tsai YY
    Eye (Lond); 2009 Feb; 23(2):294-8. PubMed ID: 18188174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibronectin eyedrops for traumatic recurrent corneal lesion.
    Nishida T; Nakagawa S; Awata T; Tani Y; Manabe R
    Lancet; 1983 Aug; 2(8348):521-2. PubMed ID: 6136683
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasmin in tear fluid of patients with corneal ulcers: basis for new therapy.
    Salonen EM; Tervo T; Törmä E; Tarkkanen A; Vaheri A
    Acta Ophthalmol (Copenh); 1987 Feb; 65(1):3-12. PubMed ID: 2437758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic administration of fibronectin: current uses and potential applications.
    Yoder MC
    Clin Perinatol; 1991 Jun; 18(2):325-41. PubMed ID: 1879111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.